Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine
Yu Liu,Yuxin Yang,Yuying Cao,Jicheng Qiu,Jingyuan Kong,Lu Zhang,Yanying Guo,Mingchuan Zhang,Xingyuan Cao,Suxia Zhang
DOI: https://doi.org/10.1111/jvp.12981
IF: 1.567
2021-01-01
Journal of Veterinary Pharmacology and Therapeutics
Abstract:The aminoglycoside antibiotic neomycin, which is used to treat external or internal bacterial infections, is primarily administered in veterinary medicine as a sulfate salt. However, no information is available on the pharmacokinetic characteristics and absolute availability of neomycin sulfate after intravenous (i.v.) and oral (p.o.) administrations in swine. Here, these parameters were studied in swine after i.v. and p.o. doses of single 15 mg/kg body weight doses. The blood samples were assessed using ultra-high-performance liquid chromatography-tandem mass/mass spectrometry (UPLC-MS/MS) and pharmacokinetic parameters were analyzed using a non-compartmental model. In swine, after the p.o. administration, the elimination half-life, mean residue time from t0 to the last collection point, mean maximum concentration, mean time to reach maximum concentration and area under concentration-time curve from t0 to the last collection point values were 12.43 +/- 7.63 h, 10.25 +/- 4.32 h, 0.11 +/- 0.07 mu g/ml, 1.92 +/- 0.97 h and 1.23 +/- 0.78 mu g center dot h/ml, respectively, whereas after the i.v. administration, the values were 5.87 +/- 1.12 h, 6.07 +/- 0.49 h, 15.80 +/- 1.32 mu g/ml, 0.30 +/- 0.38 h and 76.14 +/- 3.52 mu g center dot h/ml, respectively. The absolute bioavailability of neomycin sulfate B was 4.84%+/- 0.03.